Linked Life Data

19160361

Source:http://linkedlifedata.com/resource/pubmed/id/19160361

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-1-27
pubmed:abstractText
Hepatic surgery is presumed to improve survival of patients with liver metastases (LM) from neuroendocrine tumours (NET). This study identified LM-specific variables that could be used as additional selection criteria for aggressive treatment.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1365-2168
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
96
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
175-84
pubmed:dateRevised
2009-6-22
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease.
pubmed:affiliation
Department of General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany. andrea.frilling@usz.ch
pubmed:publicationType
Journal Article